Skip to main content
. 2020 Jun 26;9(2):94–100. doi: 10.4103/jrpp.JRPP_19_57

Table 3.

Comparison of clinical outcomes difference between groups

Parameters Octreotide group (n=58) Placebo group (n=58) P**
Blood transfusion (mean±SEM) 1.65±0.47 1.7±0.45 0.45
Rebleeding during the first 3 days (%) 3 (5.17) 1 (1.72) 0.5
Hospital stay (day) 1.96±1.00 1.65±0.84 0.44
Surgery (%) 1 (1.72) 1 (1.72) 0.77
Mortality (%) 0 3 (5.17) 0.21

**Spearman statistical test. Hb=Hemoglobin, SEM=Standard error of means